CSIMarket
 


Immucell Corp  (ICCC)
Other Ticker:  
 


Immucell's Free Cash Flow Margin by quarter

Trends, Rankings, Statistics



ICCC Free Cash Flow Margin (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change -14.98 % 46.08 % 45.43 % 38.35 % 53.13 %
Seq. Revenue Change -35.64 % 10.21 % 5.7 % 13.39 % 10.58 %
Revenue In Millions $3.86 $6.00 $5.44 $5.15 $4.54
Free Cash Flow Margin 9.67 % 10.64 % 10.8 % 5.03 % 16.09 %
Free Cash Flow Margin Total Ranking # 1809 # 1619 # 2141 # 2396 # 1664
Free Cash Flow In Millions $0.37 $0.64 $0.59 $0.26 $0.73
Y / Y Free Cash Flow Change -48.9 % - 276.26 % - -24.59 %
Seq. Free Cash Flow Change -41.51 % 8.61 % 126.99 % -64.56 % -


Commenting Second Quarter 2022 Free Cash Flow Margin
Company's Free Cash Flow Margin decreased in II. Quarter to 9.67 %, below company's average Free Cash Flow Margin.

Observing second quarter 2022 results within In Vitro & In Vivo Diagnostic Substances industry 4 other companies have achieved higher Free Cash Flow Margin. While Free Cash Flow Margin overall ranking has deteriorated compare to previous quarter from 1619 to 1809.

ICCC's Free Cash Flow Margin second quarter 2022 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 5
Healthcare Sector # 141
Overall # 1809

Free Cash Flow Margin Statistics
High Average Low
45.2 % 15.77 % 0.7 %
(Mar 31 2015)   (Jun 30 2018)




Other Free Cash Flow Margin Profitability Ratios
ICCC's Cumulative Free Cash Flow Margin
In Vitro & In Vivo Diagnostic Substances Industry Free Cash Flow Margin Trends and Statistics
Healthcare Sector Free Cash Flow Margin Statistics
Free Cash Flow Margin Profitability Trends for overall market
ICCC's Free Cash Flow Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Margin
Lowest Ranking Free Cash Flow Margin
Free Cash Flow Margin Profit Margin for ICCC's Competitors
Free Cash Flow Margin Profit Margin for Immucell's Suppliers
Free Cash Flow Margin Profit Margin for ICCC's Customers

You may also want to know
ICCC's Annual Growth Rates ICCC's Profitability Ratios ICCC's Asset Turnover Ratio ICCC's Dividend Growth
ICCC's Roe ICCC's Valuation Ratios ICCC's Financial Strength Ratios ICCC's Free Cash Flow Growth
ICCC's Roa ICCC's Inventory Turnover Ratio ICCC's Growth Rates ICCC's Dividend Comparisons


Companies with similar Free Cash Flow Margin in the quarter ending Jun 30 2022, within In Vitro & In Vivo Diagnostic Substances Industry Free Cash Flow MarginJun 30 2022 MRQ Free Cash FlowJun 30 2022 MRQ Revenue
Meridian Bioscience Inc.  21.25 %$ 14.402 $ 67.771 
Neogen Corporation  14.55 %$ 20.390 $ 140.093 
Immucell Corp  9.67 %$ 0.373 $ 3.861 
Idexx Laboratories Inc  7.65 %$ 65.850 $ 860.546 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SSL's Profile

Stock Price

SSL's Financials

Business Description

Fundamentals

Charts & Quotes

SSL's News

Suppliers

SSL's Competitors

Customers & Markets

Economic Indicators

SSL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071